Sam Brondfield, MD
University of California, San Francisco
Dr. Sam Brondfield is an Assistant Professor, hospital-based oncologist, and clinician educator at the University of California, San Francisco. His clinical focus is the care of hospitalized patients with solid tumors. He is completing a Master of Education degree at UC Berkeley and conducts medical education research projects focused on optimizing the learning experience for busy clinical trainees.
Dr. Brondfield has received UCSF Education Innovations Grants for work on trainee wellness and cognitive load, Conquer Cancer Foundation merit awards for work on financial toxicity and asynchronous learning, and clinical and small group teaching awards. He completed medical school, residency, and chief residency at UCSF, where he also served as chief hematology/oncology fellow. Dr. Brondfield looks forward to continuing his work as a clinician educator, aiming to develop a hospital-based oncology curriculum for the benefit of trainees and faculty, and is grateful to join the ASCO Education Scholars Program.
Rachel J. Buchsbaum, MD
Tufts Medical Center
Dr. Rachel Buchsbaum earned her undergraduate and medical degrees from Harvard University and Cornell University Medical College respectively. She pursued internship and residency in Internal Medicine at the Beth Israel Hospital in Boston, followed by fellowship in Hematology and Oncology at Tufts Medical Center (then called the Tufts-New England Medical Center). She has remained on faculty at Tufts Medical Center and the Tufts University School of Medicine (TUSM), where she is now Chief of the Division of Hematology Oncology and the Jane F. Desforges MD Chair in Hematology and Oncology. Her research interests include study of pathways linking the tumor microenvironment to tumor metastasis and developing novel tools for breast cancer detection. Dr. Buchsbaum has a long-standing interest in innovations in medical education, serving as Course Director for the TUSM Hematology course and Program Director for the Tufts MC Hematology Oncology fellowship program, and previously leading the Tufts GME enterprise as Associate Chief Medical Officer for Graduate Medical Education.
Tyler Paul Johnson, MD
Stanford University School of Medicine
Dr. Tyler Johnson graduated magna cum laude from Brigham Young University with a BA in American Studies in 2005. He earned his MD from the University of Pennsylvania in 2009 and then moved across the country to attend Stanford where he was a resident in internal medicine, a chief resident in internal medicine, and then a fellow in hematology/oncology, finishing his training in 2016. Upon graduation from fellowship, Dr. Johnson stayed at Stanford as a member of the GI oncology faculty. He remains at Stanford and there leads the inpatient oncology house staff service as well as serving as the senior associate program director for the oncology fellowship program. Dr. Johnson has a keen interest in medical education and additionally works as a core "Educators-4-CARE" faculty member in the medical school where he mentors small groups of medical students longitudinally. In addition, Dr. Johnson holds a special interest in teaching doctor/patient communication and is certified by the Association of Communication in Healthcare, the Ariadne initiative for improving serious illness conversations, and VitalTalk. Dr. Johnson is currently engaged in multiple curricular reform projects at Stanford including revamping the oncology fellowship curriculum and the creating training for surgery residents in communication skills.
Rami Manochakian, MD
Mayo Clinic, Florida
Dr. Rami Manochakian earned his medical degree from the University of Aleppo, Syria. He completed medicine residency and a year of chief residency at the University at Buffalo, NY. He completed Hematology/Oncology fellowship and was a chief fellow at Case Western Reserve University, Cleveland, OH. After fellowship, he joined the faculty at Case Western/Cleveland VAMC where he led a new multidisciplinary lung cancer program. In January 2017, he joined the Mayo Clinic, Florida, where he is currently an assistant professor and a thoracic oncologist at the division of Hematology/Oncology.
Medical Education is one of Dr. Manochakian’s main passions. He received honoring awards in recognition of his teaching and contribution to education. He has been involved in many educational activities at institutional level as well as with national and international medical societies. He is currently the associate director for the Hematology/Oncology fellowship and a senior fellow member of the Academy of Educational Excellence at the Mayo Clinic School of Medicine. He served on ASCO CME committee and is currently an associate member of ASCO University/E-learning editorial board.
Jonathan M. Marron, MD, MPH
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Dr. Jonathan Marron is a pediatric oncologist, bioethicist, health services researcher, and educator. He is an Instructor in Pediatrics at Harvard Medical School and Attending Physician in pediatric hematology/oncology at the Dana-Farber Cancer Institute and Boston Children’s Hospital. At the Harvard Medical School Center for Bioethics, Jonathan teaches in the medical student ethics curriculum, co-directs “Introduction to Clinical Ethics,” and directs “Pediatric Bioethics.”
Dr. Marron’s research examines the intersection of ethics and decision-making in medical practice. Much of his recent work has focused on decision-making regarding genomic sequencing and precision medicine in pediatric oncology. He has received numerous grants and awards supporting his research from the American Society of Clinical Oncology, the American Society of Pediatric Hematology/Oncology, and the National Institutes of Health. Dr. Marron’s work has been published in such journals as Cancer, American Journal of Bioethics, Pediatric Blood and Cancer, Psycho-Oncology, the AMA Journal of Ethics, the Journal of Clinical Oncology, Blood, the Journal of Oncology Practice, Pediatrics, and the Journal of Pain and Symptom Management.
Mairéad McNamara, MBBCh BAO, BMed Sci, BSc, PhD, MRCP UK, PGCE
University of Manchester/The Christie NHS Foundation Trust
Dr. Mairéad McNamara has a BSc in Biochemistry and PhD in Pharmacology (National University of Ireland (NUI), Galway). After a period of time lecturing (NUI, Galway), she commenced Medicine in University College Cork, Ireland and obtained a B Med Sci while completing her MB BCh BAO. She obtained her Certificate of satisfactory completion of specialist training (Medical Oncology) from the Royal College of Physicians of Ireland and did a three-year clinical research fellowship in Princess Margaret Cancer Centre, Toronto, Canada (2011-2014).
She was appointed in 2014 as a Senior Lecturer/Honorary Consultant in Medical Oncology (University of Manchester [UoM]/The Christie NHS Foundation Trust), and specialises in the treatment of patients with Hepatopancreaticobiliary/ Neuroendocrine tumours; involved in clinical and translational research in these subject areas. She obtained a Postgraduate Certificate in Higher Education in 2018 (UoM) and is a Faculty Member for 21st EORTC-ESMO-ECCO-AACR 2019 Workshop on Methods in Clinical Cancer Research, Netherlands.
Sarah Nagle, MD
Oregon Health & Science University
Dr. Sarah Nagle is an Assistant Professor in the Division of Hematology/Oncology at Oregon Health & Science University. Dr. Nagle completed her medical degree at Jefferson Medical College in Philadelphia. She then crossed the river to complete her Internal Medicine residency training at the Hospital of the University of Pennsylvania. She stayed at UPenn to pursue a Hematology/Oncology Fellowship and served as Chief Fellow. During her Hematology/Oncology training, she also completed a fellowship in Medical Education. She has been on faculty at OHSU since completing her fellowship in 2017. Her clinical interests focus on stem cell transplant and chimeric antigen receptor T cell therapy for lymphoma and multiple myeloma. Since starting at OHSU, Dr. Nagle has been heavily involved in medical education for medical students, residents and fellows; she is in her second year as the Associate Program Director for the Hematology/Oncology Fellowship Program.
Deepa Rangachari, MD
Beth Israel Deaconess Medical Center, Harvard Medical School
Dr. Deepa Rangachari is an Assistant Professor of Medicine at Harvard Medical School and Associate Director of the Hematology/Oncology Fellowship Program at the Beth Israel Deaconess Medical Center, where she is also a member of the Thoracic Oncology Program. She additionally serves as a key clinical and career mentor for graduate and post-graduate trainees within the institution at-large. Her work as a clinical investigator is focused on advancing the use of tumor molecular and immunologic biomarkers in the management of lung cancer. As an educator, her work has emphasized the development of curricular initiatives in patient-centered communication skills, peer coaching, simulation-based procedural training, and genomic oncology.
Jennifer E. Schwartz, MD, FRCPC
Dr. Jennifer Schwartz is the Assistant Dean of Medical Student Education, Phase 2 at Indiana University School of Medicine where she oversees all the mandatory clinical clerkships that occur in the 3rd year. Dr. Schwartz completed her medical school and Internal Medicine residency training at McGill University in Montreal, Canada and her hematology-oncology fellowship training at the University of Pittsburgh. She joined the faculty at the IU School of Medicine in the Division of Hematology-Oncology in 2003 as a member of their Bone Marrow and Stem Cell Transplantation Program. Dr. Schwartz has previously served as the co-director of the IU Simon Cancer Center Summer Research Program, the Statewide Course Director for the Introduction to Clinical Medicine and continues to be a member of the curriculum council steering committee. Dr. Schwartz serves as an associate editor for ASCO Education and she is a member of the Executive Committee for the Central Group on Educational Affairs for the Association of American Medical Colleges.
Vatché Tchekmedyian, MD, MEd
Maine Medical Center
Dr. Vatché Tchekmedyian graduated from the David Geffen School of Medicine at the University of California, Los Angeles in 2011, and completed his internship, residency and chief residency at the Brigham and Women’s Hospital. After residency he was accepted as the Comenitz Medical Education Fellow at the Brigham and Women’s Hospital, which included a Master’s in Education from the Harvard Graduate School of Education. His fellowship research focused on the use of rubric guided coaching to improve teaching skills among fourth year medical students. He went on to complete his hematology and oncology training at Memorial Sloan Kettering Cancer Center where he focused on thyroid and salivary cancers. At MSKCC he earned the John Mendelsohn Housestaff Teaching Award after his first year, and subsequently served as chief fellow where he worked to innovate the fellowship educational curriculum with a case-based series entitled “Thinking Like an Oncologist.”
Gina Villani, MD, MPH
Weill Cornell-New York Presbyterian
Dr. Gina Villani is a board-certified medical oncologist. She earned her medical degree from the State University of New York at Stony Brook. After completing a residency in Internal Medicine at SUNY of Syracuse and North Shore University Hospital, she pursued post-doctoral training in Hematology and Oncology at New York University Medical Center and Bellevue Hospital. After spending many years working within the New York City public hospital system and recognizing the disparities that exist in our current health care structure, Dr. Villani decided to pursue an education in public health and received her Master’s in Health Policy and Management from Columbia University in November of 2006.
Dr. Villani has spent the bulk of her career working with underserved populations throughout NYC and has had several leadership roles in the city hospital system as well as safety net hospitals. She currently is the Chief of Oncology at New York Presbyterian-Queens a hospital serving one of the most diverse counties in the nation.
She received a Citation of Honor from the Queens Borough president for her outstanding work in the community, a Laurel Award for her work in cancer prevention and a Women of Excellence award from the American Cancer Society.
She has had several papers and abstracts accepted for publication regarding health disparities and has served on the American Society of Clinical Oncology’s Health Disparities Committee, the Cancer Prevention Committee and the Government Relations Committee as well as served as an advisor to the American Hospital Association.
Katherine Walsh, MD
The Ohio State University
Dr. Katherine Walsh is an associate professor of clinical internal medicine at The Ohio State University. Prior to joining, she completed her medical school and residency training including chief residency at the University of Florida and her hematology/oncology fellowship at Duke University. In her clinic she focuses on myeloproliferative neoplasms as well as diagnostic work-up of cytosis and cytopenia cases. In education, her focus is medical student education where she leads the second-year medical student hematology block and the third-year medical student inpatient internal medicine clerkship. She is involved at the national level in education through the Clerkship Directors of Internal Medicine where she is an active member of the Survey and Scholarship Committee through which she has co-authored manuscripts and presented at the regional and national level. She has been recognized as an educator through induction into the Courage to Teach society at OSU and through selection for the inaugural American Society of Hematology Medical Educators Institute.